Home・Akcijų sąrašas・Medpace Holdings Inc

Medpace Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

587.72 2.7

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

575.11

Max

589.66

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-2.5M 121M
Pardavimai	727K 707M
P/E Sektoriaus vid.	33.683 68.51
Pelnas, tenkantis vienai akcijai	4.25
Pelno marža	17.158
Darbuotojai	6,500
EBITDA	-21M 134M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	+0.89% upside

Dividendai
By Acuity
Kitas uždarbis	2026-10-21

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	924M 16B
Ankstesnė atidarymo kaina	585.02
Ankstesnė uždarymo kaina	587.72

Medpace Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-03 19:26; UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

2026-07-30 19:22; UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

2026-07-29 18:44; UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

2026-07-28 23:11; UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

2026-07-27 16:56; UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

2026-07-24 18:26; UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

2026-07-22 23:22; UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

2026-07-21 19:46; UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Akcijų palyginimas

Kainos pokytis

Medpace Holdings Inc Prognozė

Kainos tikslas

By TipRanks

0.89% į viršų

12 mėnesių prognozė

Vidutinis 580.2 USD 0.89%

Aukščiausias 692 USD

Žemiausias 450 USD

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Medpace Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

11 ratings

Pirkti

Laikyti

Parduoti

Remiantis 11 analitikų, pateikusių Medpace Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.